Rare diseases
Investigational molecules
Locations
Back to Romania322 clinical trials in Craiova, Romania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations
RomaniaStudy of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy
RomaniaStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels
RomaniaStudy Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer
RomaniaStudy of Nivolumab and Ipilimumab for Patients with Stage 3 Non-Small Cell Lung Cancer Not Suitable for Surgery
RomaniaStudy on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma
RomaniaStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
RomaniaStudy on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment
RomaniaStudy of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment
RomaniaStudy on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients
RomaniaStudy of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy
RomaniaStudy on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Current trials focus on innovative treatments for pulmonary conditions, including investigations into new therapies for asthma and pulmonary fibrosis. Research evaluates medication effectiveness in improving lung function and breathing capacity.
Studies incorporate both targeted therapies and combination treatments to address various stages of respiratory diseases.
Groundbreaking research in cancer treatment explores novel therapeutic approaches for various types of cancer, with particular focus on gastric, prostate, and lung cancers.
Trials evaluate combination therapies and immunotherapy approaches for improved patient outcomes.
Studies focus on preventing and treating heart failure and related conditions, with innovative approaches to cardiovascular disease management and metabolic disorders.
Research emphasizes both preventive strategies and treatment interventions for cardiovascular conditions.
Advanced research in autoimmune conditions and inflammatory disorders, investigating new therapeutic options for various immune-mediated diseases.
Studies evaluate both targeted therapies and broader immunological approaches.
Innovative research addressing neurological disorders and mental health conditions, with focus on both therapeutic interventions and disease management.
Trials explore novel treatment approaches for complex neurological and psychiatric conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
